论文部分内容阅读
目的本文观察１１例慢性放射病的胸腺肽治疗结果及病程转归。方法以临床症状变化、造血系统造血功能、Ｔ淋巴细胞百分率、染色体畸变率变化作为慢放病恢复的综合判断标准进行分析。结果胸腺肽能促使患者的无力型神经衰弱征候群明显好转；能显著提高Ｔ淋巴细胞百分率，进而增强机体免疫力，治愈口腔粘膜溃疡。追踪观察表明，慢放病恢复时间依次为细胞免疫功能（２年），无力型神经衰弱综合症（３．５年），造血组织造血功能（５～８年），染色体畸变率（１０年）。结论按照我们拟定的慢放病恢复综合判断标准，慢放病是一种可以恢复的职业性疾病。胸腺肽有助于慢放病的治疗，且方法简单，值得临床试用
Objective To observe the results of thymosin treatment in 11 patients with chronic radiation sickness and the course of disease. Methods The changes of clinical symptoms, hematopoietic system of hematopoietic function, the percentage of T lymphocytes and chromosome aberration rate were used as the comprehensive judgment criteria for the recovery of chronic disease. Results thymosin can promote the weakness of patients with symptoms of neurasthenia significantly improved; can significantly increase the percentage of T lymphocytes, thereby enhancing the body immunity and cure oral mucosal ulcers. Follow-up observation showed that the recovery time of slow release disease followed by cellular immune function (2 years), weakness neurasthenic syndrome (3.5 years), hematopoietic tissue hematopoietic function (5-8 years), chromosome aberration rate (10 years) . Conclusion According to our comprehensive criteria for the determination of slow release, the slow release is a recoverable occupational disease. Thymosin helps slow the disease treatment, and the method is simple, it is worth clinical trial